Cannabis News
Amazon is Selling Weed and Doesn’t Even Know It
A recent investigation conducted by CBD Oracle has revealed concerning revelations regarding the availability of “hemp gummies” on major e-commerce platforms such as Amazon.com Inc (NASDAQ:AMZN), Walmart Inc (NYSE:WMT), and eBay Inc (NASDAQ:EBAY). Despite the stringent regulations against CBD and THC, thorough lab examinations have shown that many of these products contain notable amounts of delta-8 THC, a substance prohibited in numerous states.
The meticulous research by CBD Oracle involved the purchase of 56 hemp items from Amazon, including gummies and tinctures, which were then subjected to laboratory testing by InfiniteCAL Labs. The outcomes were unsettling: 30% of the products contained undisclosed CBD, violating federal guidelines, while a staggering 43% lacked any hemp-related ingredients altogether, essentially rendering them overpriced confectionery items.
Of particular concern was the identification of products with elevated levels of delta-8 THC, a psychoactive compound banned in various states. The analysis pinpointed three products with dangerously high concentrations of delta-8 THC, with the most potent gummy containing 76 mg of THC per piece, far surpassing legal limits for cannabis edibles.
Erik Paulson, PhD, the lab manager at InfiniteCAL, remarked in a press release, “If individuals are purchasing these hemp gummies from Amazon under the assumption that they will derive benefits from the contained hemp, then it’s akin to playing a game of chance. You might receive CBD-infused, THC-infused, hempseed oil-infused products, or quite possibly, a product devoid of hemp altogether.”
Furthermore, the study illuminated a prevalent issue with deceptive marketing strategies. An overwhelming 96% of products failed to provide accurate dosage information, and over half of the product descriptions made unauthorized medical assertions, potentially misleading consumers regarding the benefits of these products.
CBD Oracle’s findings underscore a market inundated with misleading practices, where unverified and potentially harmful products can easily reach unsuspecting consumers. The report urges prompt action from Amazon and other online retailers to address these concerns, advocating for stricter enforcement or reconsideration of policies concerning CBD and hemp products.
Consumer Safety Compromised: Delta-8 THC Uncovered in “Hemp Gummies”
CBD Oracle’s study has revealed a startling fact despite claims of safety and legality: a large number of “hemp gummies” sold on well-known e-commerce platforms contain high concentrations of delta-8 THC, which puts customers’ health in danger. Not only is the psychoactive chemical delta-8 THC illegal in many places, but it can also be dangerous, especially if taken accidentally or in excess.
The discovery of delta-8 THC in these goods highlights a serious gap in regulatory oversight and quality control within the hemp and CBD industries. Consumers who often seek out health goods or natural remedies face the danger of inadvertently exposing themselves to the harmful effects of delta-8 THC, which include impairment, anxiety, and other psychoactive symptoms.
This research emphasizes how important it is to have strict regulations and thorough testing procedures in place to guarantee the purity and safety of CBD and hemp products. In the absence of strict protocols, gullible customers continue to be exposed to the risks associated with items that are mislabeled or have not undergone appropriate testing and are marketed as “hemp gummies.”
Lack of Transparency on Dosage and Ingredients
The investigation conducted by CBD Oracle has brought to light not only concerning levels of delta-8 THC but also the prevalence of deceptive marketing practices within the CBD and hemp product industry. One of the most glaring issues identified is the lack of transparency regarding dosage information and product ingredients. With a staggering 96% of the products failing to provide accurate dosage information, consumers are left in the dark about the potency and potential effects of the products they purchase.
Moreover, many product descriptions make unauthorized medical claims, misleading consumers about the purported benefits of these items. This deceptive marketing tactic not only undermines consumer trust but also poses significant health risks, as individuals may rely on inaccurate information when making purchasing decisions. The absence of regulatory oversight allows such misleading claims to proliferate unchecked, further exacerbating the confusion and uncertainty surrounding CBD and hemp products.
It’s also problematic that the product’s components are not clearly stated. Given that 43% of the commodities examined had no components associated with hemp, consumers are left to doubt the reliability and effectiveness of the products they purchase. People who don’t have accurate ingredient lists and clear labeling may inadvertently consume things that don’t fit their dietary restrictions or expectations, which might cause allergic reactions or other unpleasant side effects.
All things considered, the frequency of dishonest marketing tactics emphasizes how urgently the CBD and hemp product businesses require more regulations and enforcement actions. Clear labeling, accurate dosage information, and sincere marketing strategies are essential for guaranteeing consumer safety and confidence in these gaining popularity products. In order to hold manufacturers and sellers responsible for making false claims and providing insufficient product disclosures, regulatory bodies and e-commerce platforms need to act decisively.
Urgent Measures Needed to Regulate CBD and Hemp Product Market
The revelations from CBD Oracle’s investigation call for immediate action from both regulatory bodies and e-commerce platforms. With widespread deception and potential health risks associated with “hemp gummies,” urgent measures are needed to regulate the CBD and hemp product market effectively. Regulatory agencies must prioritize developing and enforcing stringent standards to ensure the potency, purity, and safety of these products. By implementing clear guidelines and holding manufacturers accountable for compliance, regulators can prevent the distribution of mislabeled or adulterated products that pose risks to consumers.
Giants in the e-commerce space like Amazon, Walmart, and eBay also need to be proactive in stopping dishonest marketing techniques on their sites. To guarantee that product listings meet legal requirements and do not make deceptive claims about the efficacy or advantages of CBD and hemp products, stronger procedures must be put in place. Platforms should place a high priority on transparency by giving users accurate information on the dose, ingredients, and possible hazards of these goods. This will enable users to make well-informed decisions about their purchases and health.
Bottom Line
The findings of CBD Oracle’s investigation underscore the critical need for immediate action to safeguard consumers and ensure the integrity of the CBD and hemp product market. Regulatory bodies must implement stringent standards and enforcement measures to prevent the distribution of unsafe or mislabeled products. Likewise, e-commerce platforms must take proactive steps to address deceptive marketing practices and provide transparent information to consumers. By working together to enforce regulations and promote transparency, we can create a safer and more trustworthy marketplace for CBD and hemp products, ultimately protecting the well-being of consumers.
AVOIDING PRODUCTS WITH NO HEMP OR CBD IN THEM, READ ON…
